Ledger.Open graph →
SEC Form D · filed May 8, 2025

Stork Therapeutics, Inc

Offering
$2.7M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Brendan Kennedy · San Francisco, CADirectorGregg Fine · San Francisco, CAExec · Director · PromoterBrendan Kennedy · Seattle, WADirectorGregg Fine · San Francisco, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗